Home Healthcare Pharmaceuticals Psoriasis Treatment Market

Psoriasis Treatment Market Size, Share & Trends Analysis Report By Drug Class (Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, Vitamin D Analogues, Corticosteroids, Others), By Route of Administration (Parenteral, Oral, Topical), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 19, 2026 | Author: Debashree B | Format: | Report Code: SR7848DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Psoriasis Treatment Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Tumor Necrosis Factor Inhibitors
    2. Interleukin Inhibitors
    3. Vitamin D Analogues
    4. Corticosteroids
    5. Others
  2. Psoriasis Treatment Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Parenteral
    2. Oral
    3. Topical
  3. Psoriasis Treatment Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
  4. Regional Psoriasis Treatment Market
    1. North America
      1. North America Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. North America Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      3. North America Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.S. Psoriasis Treatment Market
        1. U.S. Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. U.S. Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. U.S. Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      5. Canada Psoriasis Treatment Market
        1. Canada Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Canada Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Canada Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
    2. Europe
      1. Europe Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. Europe Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      3. Europe Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.K. Psoriasis Treatment Market
        1. U.K. Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. U.K. Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. U.K. Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      5. Germany Psoriasis Treatment Market
        1. Germany Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Germany Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Germany Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      6. France Psoriasis Treatment Market
        1. France Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. France Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. France Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      7. Spain Psoriasis Treatment Market
        1. Spain Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Spain Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Spain Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      8. Italy Psoriasis Treatment Market
        1. Italy Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Italy Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Italy Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      9. Russia Psoriasis Treatment Market
        1. Russia Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Russia Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Russia Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      10. Nordic Psoriasis Treatment Market
        1. Nordic Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Nordic Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Nordic Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      11. Benelux Psoriasis Treatment Market
        1. Benelux Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Benelux Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Benelux Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      12. Rest of Europe Psoriasis Treatment Market
        1. Rest of Europe Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Rest of Europe Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Rest of Europe Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
    3. APAC
      1. APAC Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. APAC Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      3. APAC Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. China Psoriasis Treatment Market
        1. China Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. China Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. China Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      5. Korea Psoriasis Treatment Market
        1. Korea Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Korea Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Korea Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      6. Japan Psoriasis Treatment Market
        1. Japan Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Japan Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Japan Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      7. India Psoriasis Treatment Market
        1. India Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. India Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. India Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      8. Australia Psoriasis Treatment Market
        1. Australia Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Australia Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Australia Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      9. Taiwan Psoriasis Treatment Market
        1. Taiwan Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Taiwan Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Taiwan Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      10. South East Asia Psoriasis Treatment Market
        1. South East Asia Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. South East Asia Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. South East Asia Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      11. Rest of Asia-Pacific Psoriasis Treatment Market
        1. Rest of Asia-Pacific Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Rest of Asia-Pacific Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Rest of Asia-Pacific Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. Middle East and Africa Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      3. Middle East and Africa Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. UAE Psoriasis Treatment Market
        1. UAE Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. UAE Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. UAE Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      5. Turkey Psoriasis Treatment Market
        1. Turkey Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Turkey Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Turkey Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      6. Saudi Arabia Psoriasis Treatment Market
        1. Saudi Arabia Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Saudi Arabia Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Saudi Arabia Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      7. South Africa Psoriasis Treatment Market
        1. South Africa Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. South Africa Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. South Africa Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      8. Egypt Psoriasis Treatment Market
        1. Egypt Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Egypt Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Egypt Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      9. Nigeria Psoriasis Treatment Market
        1. Nigeria Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Nigeria Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Nigeria Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      10. Rest of MEA Psoriasis Treatment Market
        1. Rest of MEA Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Rest of MEA Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Rest of MEA Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
    5. LATAM
      1. LATAM Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. LATAM Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      3. LATAM Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. Brazil Psoriasis Treatment Market
        1. Brazil Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Brazil Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Brazil Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      5. Mexico Psoriasis Treatment Market
        1. Mexico Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Mexico Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Mexico Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      6. Argentina Psoriasis Treatment Market
        1. Argentina Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Argentina Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Argentina Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      7. Chile Psoriasis Treatment Market
        1. Chile Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Chile Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Chile Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      8. Colombia Psoriasis Treatment Market
        1. Colombia Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Colombia Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Colombia Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
      9. Rest of LATAM Psoriasis Treatment Market
        1. Rest of LATAM Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Tumor Necrosis Factor Inhibitors
          2. Interleukin Inhibitors
          3. Vitamin D Analogues
          4. Corticosteroids
          5. Others
        2. Rest of LATAM Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Parenteral
          2. Oral
          3. Topical
        3. Rest of LATAM Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.